Your browser doesn't support javascript.
loading
Metformin and the Liver: Unlocking the Full Therapeutic Potential.
Perazza, Federica; Leoni, Laura; Colosimo, Santo; Musio, Alessandra; Bocedi, Giulia; D'Avino, Michela; Agnelli, Giulio; Nicastri, Alba; Rossetti, Chiara; Sacilotto, Federica; Marchesini, Giulio; Petroni, Maria Letizia; Ravaioli, Federico.
Afiliação
  • Perazza F; Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40138 Bologna, Italy.
  • Leoni L; Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40138 Bologna, Italy.
  • Colosimo S; Doctorate School of Nutrition Science, University of Milan, 20122 Milan, Italy.
  • Musio A; Centro Hercolani S.r.l., 40123 Bologna, Italy.
  • Bocedi G; U.O. Diabetologia, Ospedale C. Magati, Scandiano, 42019 Reggio Emilia, Italy.
  • D'Avino M; S.C. Endocrinologia Arcispedale Santa Maria Nuova, 42123 Reggio Emilia, Italy.
  • Agnelli G; Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40138 Bologna, Italy.
  • Nicastri A; Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40138 Bologna, Italy.
  • Rossetti C; Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40138 Bologna, Italy.
  • Sacilotto F; Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40138 Bologna, Italy.
  • Marchesini G; Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40138 Bologna, Italy.
  • Petroni ML; Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40138 Bologna, Italy.
  • Ravaioli F; Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40138 Bologna, Italy.
Metabolites ; 14(4)2024 Mar 25.
Article em En | MEDLINE | ID: mdl-38668314
ABSTRACT
Metformin is a highly effective medication for managing type 2 diabetes mellitus. Recent studies have shown that it has significant therapeutic benefits in various organ systems, particularly the liver. Although the effects of metformin on metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis are still being debated, it has positive effects on cirrhosis and anti-tumoral properties, which can help prevent the development of hepatocellular carcinoma. Furthermore, it has been proven to improve insulin resistance and dyslipidaemia, commonly associated with liver diseases. While more studies are needed to fully determine the safety and effectiveness of metformin use in liver diseases, the results are highly promising. Indeed, metformin has a terrific potential for extending its full therapeutic properties beyond its traditional use in managing diabetes.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article